Case Reports in Radiology

Case Reports in Radiology / 2012 / Article

Case Report | Open Access

Volume 2012 |Article ID 574849 | 5 pages | https://doi.org/10.1155/2012/574849

Isolated Central Sulcus Hemorrhage: A Rare Presentation Most Frequently Associated with Cerebral Amyloid Angiopathy

Academic Editor: R. Dammers
Received05 Nov 2012
Accepted23 Nov 2012
Published11 Dec 2012

Abstract

Central sulcus hemorrhage is a rare imaging finding that can be related to cerebral amyloidosis in a normotensive non-traumatic elderly patient and present as an isolated finding or in association with other areas of involvement. We report a case presenting with an isolated central sulcus hemorrhage on computed tomography. Further imaging work-up excluded other potential causes of peripheral hemorrhages and established a putative diagnosis of cerebral amyloidosis.

1. Introduction

Intracranial hemorrhage could be located within the deep white matter, cortical/subcortical, subarachnoid, subdural, epidural, or intraventricular locations. The most common etiologies for intracranial bleeding include trauma and hypertension. Cerebral amyloid angiopathy (CAA) is a common cause of non-traumatic peripheral intracranial hemorrhage in a normotensive patient, and may present as an isolated cortical or subcortical hemorrhage. Imaging evaluation supplements the nonspecific clinical features and helps to characterize the etiology of the hemorrhage and associated complications. Prompt diagnosis of acute as well as chronic presentations of cerebral amyloidosis is important and would result in appropriate management and care.

2. Case Report

An 84-year-old woman with history of breast cancer presents to the emergency department with intermittent numbness and paresthesias of the right upper and lower extremities for two days. There is no associated headache, vertigo, or vision problem during the course of illness. There is no history of trauma. There were no constitutional symptoms or chest pain and palpitations. Patient denied any history of unusual bruising, bleeding, or coagulation problems. There is no relevant family history. Vitals signs were stable. Neurological examination was unremarkable without any sensory or motor deficits. The laboratory values were normal.

Unenhanced computed tomographic (CT) head scan demonstrated increased attenuation along the left cerebral convexity consistent with isolated central sulcus hemorrhage without any mass effect or midline shift (Figure 1). Magnetic resonance (MR) imaging confirmed isolated central sulcus subarachnoid hemorrhage and also demonstrated adjacent areas of superficial siderosis and cortical/subcortical hemorrhages within the left cerebral hemisphere (Figure 2). Nonspecific white matter changes were also noted (Figure 3). Subsequent CT and MR angiograms were unremarkable without any aneurysms or vascular malformations. A working diagnosis of CAA was made based on Boston criteria [1]. Patient was monitored and discharged after stable hospital course with further clinic followup and instructions to avoid anticoagulation and antiplatelet agents. Follow-up CT head scan demonstrated interval resolution of the left central sulcus hemorrhage.

Other similar cases with findings of isolated central sulcus hemorrhage and a diagnosis of cerebral amyloidosis based on Boston criteria are illustrated in Figures 4 and 5.

3. Discussion

Various etiologies summarized in Table 1 can present with intracranial hemorrhage, especially within the cortical or subcortical areas on imaging [25]. The pattern of bleeding in CAA is peripheral, cortical or subcortical, micro-and macrohemorrhages with sparing of the deep white matter, basal ganglia, and thalami [6]. Cerebellar and intraventricular involvement is rare. The common etiologies for hemorrhage in a non-traumatic setting are usually related to hypertension and aneurysms. Hypertensive hemorrhages occur centrally within the thalamus and basal ganglia. Cerebral aneurysms are more common with a family history and present with rupture and bleeding, usually within the vicinity of the aneurysm. Trauma related hemorrhages are usually seen within the inferior frontal and temporal regions that are prone to contusion and are associated with epidural or subdural hematomas in the region of coup and contrecoup injuries. Vascular malformations present as isolated cortical or extra-axial hemorrhages. CT or MR angiograms help in characterization of possible causes of peripheral intracranial hemorrhages such as aneurysms and vascular malformations.


(i) Amyloid angiopathy (cortical/subcortical in location, may be associated with subarachnoid and subdural hemorrhages)
(ii) Aneurysm rupture (subarachnoid and cisternal)
(iii) Arterial dissection (subarachnoid hemorrhage, majority involve the posterior circulation)
(iv) Bleeding diathesis (may show fluid-blood levels, associated with thrombocytopenia or abnormal prothrombin time)
(v) Drug abuse (intraparenchymal or subarachnoid hemorrhage)
(vi) Hypertension (central, involving the thalamus and basal ganglia)
(vii) Malignancy (subcortical, associated edema and mass effect)
(viii) Posterior reversible encephalopathy syndrome or PRES (focal intracerebral and subarachnoid hemorrhage with characteristic signal changes)
(ix) Trauma (predilection for inferior frontal and temporal lobes)
(x) Vascular malformations (subarachnoid or cortical hemorrhages, better characterized on CT or MR angiograms)
(xi) Vasculitis (intraparenchymal and associated with multiple areas of subcortical infarctions)
(xii) Venous thrombosis (subcortical)

Cerebral amyloidosis is one of the etiologies for spontaneous non-traumatic cortical or subcortical bleed in a normotensive patient. Amyloid deposition in the brain occurs within various pathologies such as Alzheimer’s dementia, Creutzfeld Jacobs’s disease, spongiform encephalopathies, and postradiation necrosis or can be rarely hereditary [6]. Deposition of amyloid within the cortical, subcortical, and leptomeningeal cerebral vessels results in increased fragility, hemorrhages, microaneurysms, and vascular irregularity or stenosis [7, 8]. Cerebral amyloidosis can be asymptomatic or clinically present with symptoms related to acute or chronic hemorrhage and ischemia.

Cerebral amyloidosis commonly presents as peripheral cortical or subcortical hemorrhage but other rare and nonspecific patterns have been described in Table 2 [912]. The finding of a central sulcus hemorrhage is rare, but reported to be most frequently associated with amyloid angiopathy [13, 14]. The imaging modalities utilized during evaluation of an extra-axial or cortical-subcortical hemorrhage are described in Table 3. An acute hemorrhage can be identified easily on noncontrast CT imaging and is often the first imaging modality of choice. MR imaging, especially FLAIR (fluid attenuation inversion recovery) and gradient echo (GRE) or susceptibility weighted imaging (SWI) are helpful for confirmation and characterization of smaller cortical or subcortical bleeds. It also helps to identify other areas of chronic involvement. CT and MR angiograms exclude other common etiologies with cortical or subcortical bleeding. Boston criteria provide integration and standardization of clinical and imaging findings with diagnostic categorization (definite, probable with pathological evidence, and probable and possible diagnoses) based on clinical, histopathological, and MRI findings [1]. A biopsy is not usually warranted, and if obtained, staining of the amyloid with Congo red under polarized light demonstrates characteristic yellow green birefringence. Radiological work up in an elderly non-traumatic normotensive patient with cortical or subcortical hemorrhage excludes other causes of hemorrhage. Imaging in conjunction with clinical presentation establishes a putative diagnosis of cerebral amyloidosis. Management is currently limited and relies on optimal control of blood pressure, use of corticosteroids, and avoidance of antiplatelet agents and Warfarin [5, 15, 16]. Further understanding of the molecular pathogenesis would elucidate the role of immunosuppressants and lipid lowering drugs and help in the development of disease modifying therapies [8].


(i) Intracranial hemorrhage:
 (a) Acute and chronic cortical, subcortical, and rarely intraventricular
 (b) Spares the deep white matter, thalamus, and basal ganglia
 (c) Central sulcus hemorrhage
 (d) Characteristically multiple, bilateral, peripheral, and lobulated hemorrhages with coexisting old hemorrhages support the diagnosis
(ii) Leukoencephalopathy
(iii) Atrophy and cerebral volume loss
(iv) Vascular luminal narrowing and ischemia
(v) Amyloidoma simulating a mass


(i) Non-contrast CT: initial test of choice
(ii) MRI:
 (a) FLAIR—acute or subacute hemorrhage (non-specific)
 (b) GRE or SWI—decreased signal and blooming in areas of prior hemorrhage
(iii) CT and MR angiograms: diagnosis and characterization of aneurysms, AVM, and vasculitits
(iv) Angiography: limited value, invasive procedure

4. Conclusion

Imaging plays an important role in recognition of typical patterns of various types of intracranial hemorrhage. It complements the clinical diagnosis and guides further management. Cerebral amyloidosis is a diagnosis of exclusion with varied clinical and imaging presentations. The typical imaging findings include a peripheral cortical or subcortical hemorrhage with other areas of chronic hemorrhage in an elderly, normotensive, and non-traumatic setting. As presented in our cases, an isolated central sulcus hemorrhage is rare and is reported to be most frequently associated with cerebral amyloidosis. Although histopathological diagnosis is seldom pursued, an isolated central sulcus hemorrhage may suggest a putative diagnosis of cerebral amyloid angiopathy, especially when further imaging and clinical presentation exclude alternative diagnoses.

Abbreviations

AVM:Arteriovenous malformation
CAA:Cerebral amyloid angiopathy
CT:Computed tomography
FLAIR:Fluid attenuation inversion recovery
GRE:Gradient echo
MRI:Magnetic resonance imaging
PRES:Posterior reversible encephalopathy syndrome
SWI:Susceptibility weighted imaging.

References

  1. K. A. Knudsen, J. Rosand, D. Karluk, and S. M. Greenberg, “Clinical diagnosis of cerebral amyloid angiopathy: validation of the boston criteria,” Neurology, vol. 56, no. 4, pp. 537–539, 2001. View at: Google Scholar
  2. D. Refai, J. A. Botros, R. G. Strom, C. P. Derdeyn, A. Sharma, and G. J. Zipfel, “Spontaneous isolated convexity subarachnoid hemorrhage: presentation, radiological findings, differential diagnosis, and clinical course-clinical article,” Journal of Neurosurgery, vol. 109, no. 6, pp. 1034–1041, 2008. View at: Publisher Site | Google Scholar
  3. V. Cuvinciuc, A. Viguier, L. Calviere et al., “Isolated acute nontraumatic cortical subarachnoid hemorrhage,” American Journal of Neuroradiology, vol. 31, no. 8, pp. 1355–1362, 2010. View at: Publisher Site | Google Scholar
  4. J. G. Morris, M. Fisher, and R. A. Carandang, “Cortical vein thrombosis as a mimic for isolated cortical subarachnoid hemorrhage and transient ischemic attack,” Case Reports in Neurology, vol. 2, no. 2, pp. 63–68, 2010. View at: Publisher Site | Google Scholar
  5. S. D. Smith and C. J. Eskey, “Hemorrhagic stroke,” Radiologic Clinics of North America, vol. 49, no. 1, pp. 27–45, 2011. View at: Publisher Site | Google Scholar
  6. A. Biffi and S. M. Greenberg, “Cerebral amyloid angiopathy: a systematic review,” Journal of Clinical Neurology, vol. 7, no. 1, pp. 1–9, 2011. View at: Publisher Site | Google Scholar
  7. R. Grysiewicz and P. B. Gorelick, “Update on amyloid-associated intracerebral haemorrhage,” European Neurological Review, vol. 7, no. 1, pp. 22–24, 2012. View at: Google Scholar
  8. M. Yamada and H. Naiki, “Cerebral amyloid angiopathy,” Progress in Molecular Biology and Translational Science, vol. 107, pp. 41–78, 2012. View at: Publisher Site | Google Scholar
  9. T. Ohshima, T. Endo, H. Nukui, S. I. Ikeda, D. Allsop, and T. Onaya, “Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage,” Stroke, vol. 21, no. 3, pp. 480–483, 1990. View at: Google Scholar
  10. R. Y. Zhan, Y. Tong, J. F. Shen et al., “Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage,” Journal of Zhejiang University. Science, vol. 5, no. 10, pp. 1262–1269, 2004. View at: Google Scholar
  11. S. Brunot, A. Fromont, F. Ricolfi, T. Moreau, and M. Giroud, “Focal subarachnoid hemorrhage and cerebral amyloid angiopathy: a non-fortuitous association,” Revue Neurologique, vol. 166, no. 1, pp. 83–89, 2010. View at: Publisher Site | Google Scholar
  12. C. P. Chao, A. L. Kotsenas, and D. F. Broderick, “Cerebral amyloid angiopathy: CT and MR imaging findings,” Radiographics, vol. 26, no. 5, pp. 1517–1531, 2006. View at: Publisher Site | Google Scholar
  13. J. Linn, “Central sulcus focal subarachnoid hemorrhage in the elderly: cerebral amyloid angiopathy is the most frequent cause,” American Journal of Neuroradiology, vol. 32, no. 8, p. E161, 2011. View at: Publisher Site | Google Scholar
  14. M. Katoh, M. Yoshino, K. Asaoka et al., “A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign?” Surgical Neurology, vol. 68, no. 4, pp. 457–460, 2007. View at: Publisher Site | Google Scholar
  15. H. Arima, C. Tzourio, C. Anderson et al., “Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the progress trial,” Stroke, vol. 41, no. 2, pp. 394–396, 2010. View at: Publisher Site | Google Scholar
  16. S. Schroeter, K. Khan, R. Barbour et al., “Immunotherapy reduces vascular amyloid-β in PDAPP mice,” Journal of Neuroscience, vol. 28, no. 27, pp. 6787–6793, 2008. View at: Publisher Site | Google Scholar

Copyright © 2012 Murthy R. Chamarthy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

3411 Views | 625 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.